In type 2 diabetes, smoking cessation is associated with deterioration in glycemic control and this is unrelated to weight gain

2016 ◽  
Vol 120 ◽  
pp. S79
Author(s):  
Takako Kikuchi ◽  
Kenichiro Enooku ◽  
Akifumi Kushiyama ◽  
Yoko Yoshida ◽  
Sayaka Wakabayashi ◽  
...  
2021 ◽  
Vol 9 (1) ◽  
pp. e002035
Author(s):  
Merel M Ruissen ◽  
Hannah Regeer ◽  
Cyril P Landstra ◽  
Marielle Schroijen ◽  
Ingrid Jazet ◽  
...  

IntroductionLockdown measures have a profound effect on many aspects of daily life relevant for diabetes self-management. We assessed whether lockdown measures, in the context of the COVID-19 pandemic, differentially affect perceived stress, body weight, exercise and related this to glycemic control in people with type 1 and type 2 diabetes.Research design and methodsWe performed a short-term observational cohort study at the Leiden University Medical Center. People with type 1 and type 2 diabetes ≥18 years were eligible to participate. Participants filled out online questionnaires, sent in blood for hemoglobin A1c (HbA1c) analysis and shared data of their flash or continuous glucose sensors. HbA1c during the lockdown was compared with the last known HbA1c before the lockdown.ResultsIn total, 435 people were included (type 1 diabetes n=280, type 2 diabetes n=155). An increase in perceived stress and anxiety, weight gain and less exercise was observed in both groups. There was improvement in glycemic control in the group with the highest HbA1c tertile (type 1 diabetes: −0.39% (−4.3 mmol/mol) (p<0.0001 and type 2 diabetes: −0.62% (−6.8 mmol/mol) (p=0.0036). Perceived stress was associated with difficulty with glycemic control (p<0.0001).ConclusionsAn increase in perceived stress and anxiety, weight gain and less exercise but no deterioration of glycemic control occurs in both people with relatively well-controlled type 1 and type 2 diabetes during short-term lockdown measures. As perceived stress showed to be associated with glycemic control, this provides opportunities for healthcare professionals to put more emphasis on psychological aspects during diabetes care consultations.


2002 ◽  
Vol 22 (1_suppl) ◽  
pp. 80-91 ◽  
Author(s):  
Stephanie R. Earnshaw ◽  
Anke Richter ◽  
Stephen W. Sorensen ◽  
Thomas J. Hoerger ◽  
Katherine A. Hicks ◽  
...  

Background Several interventions can be applied to prevent complications of type 2 diabetes. This article examines the optimal allocation of resources across 4 interventions to treat patients newly diagnosed with type 2 diabetes. The interventions are intensive glycemic control, intensified hypertension control, cholesterol reduction, and smoking cessation. Methods A linear programming model was designed to select sets of interventions to maximize quality-adjusted life years (QALYs), subject to varied budget and equity constraints. Results For no additional cost, approximately 211,000 QALYs can be gained over the lifetimes of all persons newly diagnosed with diabetes by implementing interventions rather than standard care. With increased availability of funds, additional health benefits can be gained but with diminishing marginal returns. The impact of equity constraints is extensive compared to the solution with the same intervention costs and no equity constraint. Under the conditions modeled, intensified hypertension control and smoking cessation interventions were provided most often, and intensive glycemic control and cholesterol reduction interventions were provided less often. Conclusions A resource allocation model identifies trade-offs involved when imposing budget and equity constraints on care for individuals with newly diagnosed diabetes.


Diabetes Care ◽  
2004 ◽  
Vol 27 (7) ◽  
pp. 1577-1583 ◽  
Author(s):  
S. M. Strowig ◽  
M. L. Aviles-Santa ◽  
P. Raskin

2014 ◽  
Vol 12 (4) ◽  
pp. 29-29
Author(s):  
Helena de Wit ◽  
Gerald M. Vervoort ◽  
Henry J. Jansen ◽  
Wim J.C. de Grauw ◽  
Bastiaan E. de Galan ◽  
...  

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Suthee Saritsiri ◽  
Pongsri Panintrarux ◽  
Sukitta Kuykomoot ◽  
Chawasri Poonvutikul

Type 2 diabetes (T2DM) necessitates early and effective treatment to delay or prevent micro- and macrovascular complications associated with diabetes. Monotherapy often fails after a period of treatment, so that multiple drugs are needed to achieve effective glycemic control. It is known that insulin is very effective in reducing hyperglycemia and may improve β-cell function in patients with T2DM. Based on the improved understanding of the pathophysiology and natural history of T2DM, insulin therapy should be introduced sooner rather than later to sustain glycemic targets. Adding oral antidiabetic drugs (OAD) to insulin can improve glycemic control and potentially lower the required insulin dose, resulting in less weight gain and lower risk for hypoglycemia. The treatto-target algorithms of the recent studies combining OADs plus insulin have demonstrated that patients can reach glycemic treatment targets with low risk of hypoglycemia, greater convenience and with limited weight gain. This article presents the pharmacologic and physiologic aspects of combination treatment of oral agents with insulin in T2DM and elaborates current options available for this combination therapy. The evidence along with potential advantages and drawbacks of such regimens are discussed.


Sign in / Sign up

Export Citation Format

Share Document